Urolithins: Potential Biomarkers of Gut Dysbiosis and Disease Stage in Parkinson’s Patients
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
). Besides, their microbiome was characterized by predictive functions of lipopolysaccharide biosynthesis and metabolism of glutathione, cysteine and methionine that could indirectly reflect the gut pro-inflammatory status. Urolithin detection in urine is a feasible, non-invasive and fast approach that can reflect gut microbiome dysbiosis and intestinal inflammation in Parkinson's disease patients. Our current study could provide novel strategies for improving diagnostics, and for preventing and treating disease progression in microbiota-based interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“because of dysbiosis, lipid, amino acid and energy metabolism are often dysregulated in PD patients [96,97,98,99,100]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [100]
In the citing paper
“disease severity has been associated with lower urine levels of urolithin, an anti-inflammatory molecule produced by the gut microbiota upon polyphenols intake [100]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [100]
Citations
Cites
Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,347
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Challenges in the diagnosis of Parkinson's disease
Tolosa, E., Garrido, A., Scholz, S. W., & Poewe, W. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00030-2 · Cited by 1,874
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281
Current Understanding of Dysbiosis in Disease in Human and Animal Models
DeGruttola, A. K., Low, D., Mizoguchi, A., & Mizoguchi, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000750 · Cited by 1,122
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874
Lewis, J. D., Chen, E. Z., Baldassano, R. N., Otley, A. R., Griffiths, A. M., Lee, D., Bittinger, K., Bailey, A., Friedman, E. S., Hoffmann, C., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.09.008 · Cited by 823
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J., & Balskus, E. P. (2019) · Science · doi:10.1126/science.aau6323 · Cited by 753
Larrosa, M., González-Sarrías, A., Yáñez-Gascón, M. J., Selma, M. V., Azorín-Ortuño, M., Toti, S., Tomás-Barberán, F., Dolara, P., & Espín, J. C. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.04.012 · Cited by 504
Self-citationDysbiosis of gut microbiota and microbial metabolites in Parkinson's disease
Sun, M.-F., & Shen, Y.-Q. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.04.004 · Cited by 445
Research works printed but not linked: 4
- Hill, 2021, Front. Neurosci., 15, 1
- Sun, 2018, Ageing Res. Rev., 45, 53, 10.1016/j.arr.2018.04.004 · DOI · Paper page
- Smirnova, 2005, Biochemistry, 70, 1199
- Zheng, 2017, Front. Microbiol., 8, 1
Cited by
Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders
Zheng, Y., Bonfili, L., Wei, T., & Eleuteri, A. M. (2023) · Nutrients · doi:10.3390/nu15214631 · Cited by 175
Kandpal, M., Indari, O., Baral, B., Jakhmola, S., Tiwari, D., Bhandari, V., Pandey, R. K., Bala, K., Sonawane, A., & Jha, H. C. (2022) · Metabolites · doi:10.3390/metabo12111064 · Cited by 159
Approach to the diagnosis and management of dysbiosis
Alagiakrishnan, K., Morgadinho, J., & Halverson, T. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1330903 · Cited by 91
(Poly)phenol-related gut metabotypes and human health: an update
Hu, J., Mesnage, R., Tuohy, K. M., Heiß, C., & Rodriguez‐Mateos, A. (2024) · Food & Function · doi:10.1039/d3fo04338j · Cited by 91
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Metadata
- Authors
- Romo-Vaquero, M., Fernández-Villalba, E., Gil-Martinez, A.-L., Cuenca-Bermejo, L., Espín, J. C., Herrero, M. T., & Selma, M. V.
- Affiliations
- Laboratory of Food & Health, Research Group on Quality, Safety and Bioactivity of Plant Foods, CEBAS-CSIC, Campus de Espinardo, Murcia 30100, Spain
- Institute of Biomedical Research of Murcia (IMIB), Campus de Ciencias de la Salud, Carretera Buenavista s/n, El Palmar, Murcia 30120, Spain
- Instituto Murciano de Investigación Biosanitaria (ES)
- Corresponding author
- Herrero, María Trinidad
- Venue
- Food & Function
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2022
- Volume
- 13
- Issue
- 11
- Pages
- 6306-6316
- ISSN
- 2042-6496 (ISSN-L)
- 2042-650X
- OpenAlex
- W4282928102
- Cited by
- 54
- References
- 44
- Citations by year
- 2026: 16 · 2025: 11 · 2024: 16 · 2023: 7 · 2022: 4
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Food & Function (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by-nc)
- Hispana (submittedVersion, cc-by-nc-nd)
- Funders
- Consejo Superior de Investigaciones Científicas (PIE201570I005)
- Fundación Séneca (FS/20880/PI/18)
- Ministerio de Ciencia e Innovación (AGL2015-64124-R and PID2019-103914RB-I00)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Nursing › Nutrition and Dietetics › Pomegranate: compositions and health benefits
- Keywords
- urolithins, Parkinson's disease, gut dysbiosis, gut microbiota, biomarkers, disease stage, intestinal inflammation, lipopolysaccharide biosynthesis, glutathione metabolism, cysteine and methionine metabolism, urinary biomarkers, non-invasive diagnosis, microbiota-targeted interventions
- MeSH terms
- Gastrointestinal Microbiome, Bacteria, Humans, Parkinson Disease, Biomarkers, Juglans, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Urolithins: Potential Biomarkers of Gut Dysbiosis and Disease Stage in Parkinson’s Patients. https://app.cochat.ai/papers/10.1039/d2fo00552b
- The paper
- Romo-Vaquero, M., Fernández-Villalba, E., Gil-Martinez, A.-L., Cuenca-Bermejo, L., Espín, J. C., Herrero, M. T., & Selma, M. V. (2022). Urolithins: Potential Biomarkers of Gut Dysbiosis and Disease Stage in Parkinson’s Patients. Food & Function. https://doi.org/10.1039/d2fo00552b
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.